Brighton Collaboration

Brighton Collaboration is a Swiss non-profit organization that builds trust in vaccine safety through rigorous science and case definitions for adverse events. The headquarters location is not specified on the website.

Here are key aspects of the company:

• Products & Services: The organization develops case definitions, companion guides, and templates such as BRAVATO to evaluate the safety and features of new platform vaccines.
• Industries: Their work focuses primarily on vaccine development, including viral vector, nucleic acid, protein, and inactivated virus candidates for diseases like COVID-19.
• Innovation: They utilize specific methodologies like the Benefit-Risk Assessment of Vaccines by Technology (BRAVATO) to assess novel technologies such as mRNA delivery systems and recombinant spike proteins.

The Brighton Collaboration serves as a critical resource for evaluating adverse events following immunization across various emerging vaccine platforms.